Primary malignant liver tumors in children

Indian Journal of Pediatrics

Volumn 79, Issue 6, 2012, Pages 793-800

  Agarwala, Sandeep ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Children; Hepatoblastoma; Hepatocellular carcinoma; Primary malignant liver tumors

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; IRINOTECAN; PIRARUBICIN; VINCRISTINE;

ANGIOSARCOMA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CARDIOTOXICITY; CHILDHOOD CANCER; CONFERENCE PAPER; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER SARCOMA; LIVER TUMOR; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; OTOTOXICITY; OVERALL SURVIVAL; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RHABDOID TUMOR; RHABDOMYOSARCOMA; RISK ASSESSMENT; UNDIFFERENTIATED CARCINOMA;

CARCINOMA, HEPATOCELLULAR; CHILD; COMBINED MODALITY THERAPY; HEMANGIOSARCOMA; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; RHABDOID TUMOR; RHABDOMYOSARCOMA; SARCOMA; TREATMENT OUTCOME;

EID: 84864285970     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-012-0704-1     Document Type: Conference Paper

References (90)

1. Stocker JT. Hepatic tumors in children. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver disease in children. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 915.
2. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol. 1983;14:512-37.
3. Pham TH, Iqbal CW, Grams JM, et al. Outcomes of primary liver cancer in children: an appraisal of experience. J Pediatr Surg. 2007;42:834-9. (Pubitemid 46719220)
4. Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology. 2003;38:560-6. (Pubitemid 37052143)
5. Mann JR, Kasthuri N, Raafat F, et al. Malignant hepatic tumours in children: incidence, clinical features and aetiology. Paediatr Perinat Epidemiol. 1990;4:276-89. (Pubitemid 20314325)
6. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med. 1997;336:1855-9.
7. Chen DS. Hepatitis B vaccination: the key toward eradication of hepatitis B. J Hepatol. 2009;50:805-16.
8. Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol. 2000;1:94-100.
9. Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer. 2002;94:1111-20. (Pubitemid 34150867)
10. Aronson DC, Schnater JM, Staalman CR, et al. Predective value of pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol. 2005;23:1245-52. (Pubitemid 46202282)
11. Otte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2004;42:74-83. (Pubitemid 38173460)
12. Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer. 2004;40:411-21. (Pubitemid 38121279)
13. Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37:123-32. (Pubitemid 46092102)
14. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey, 1974. J Pediatr Surg. 1975;10:329-37.
15. Ross JA. Hepatoblastoma and birth weight: too little, too big, or just right? J Pediatr. 1997;130:516-7. (Pubitemid 27492638)
16. Stocker J, Conran R, Selby D. Tumor and pseudo tumors of the liver. London: Chapman & Hall; 1998.
17. DA Deugrate, Atkinson JB. Liver tumors. In: Grosfeld JL, O'Neill Jr JA, Fonkalsurd EW, Coran AG, eds. Pediatric surgery. 6th ed. Philadelphia: Mosby-Elsevier; 2006. pp. 502-14.
18. Albrecht S, von Schweinitz D, Waha A, et al. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res. 1994;54:5041-4.
19. Tan TY, Amor DJ. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health. 2006;42:486-90. (Pubitemid 44252516)
20. Aretz S, Koch A, Uhlhaas S, et al. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer. 2006;47:811-8. (Pubitemid 44476759)
21. McLaughlin CC, Baptiste MS, Schymura MJ, et al. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol. 2006;163:818-28.
22. Maruyama K, Ikeda H, Koizumi T, et al. Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birth weight. Pediatr Int. 2000;42:492-8.
23. Meyers R, Aronson DC, von Schweinitz D, Zimmerman A, Malogolowkin MH. Pediatric liver tumors. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Wolters Kluwer and Lippincott Williams & Wilkins; 2011. pp. 838-60.
24. Ehrlich P, Greenberg M, Filler RM. Improved long term survival with preoperative chemotherapy for hepatoblastoma. J Pediatr Surg. 1997;32:999-1003. (Pubitemid 27349012)
25. Weinblatt M, Siegel S, Siegel M, et al. Preoperative chemotherapy for unresectable primary hepatic malignancy in children. Cancer. 1982;50:1061-4. (Pubitemid 12062882)
26. Hiyama E, Yamaoka H, Matsunaga T, et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer. 2004;91:972-9 (Pubitemid 39273793)
27. Chitraghar S, Iyer VK, Agarwala S, DattaGupta S, Sharma A,Wari MN. Loss of heterozogosity on chromosome 11p15.5 and relapse in hepatoblastoma. Eur J Pediatr Surg. 2011;21:50-3.
28. Chopra A, Iyer VK, Agarwala S, et al. Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication. Pediatr Surg Int. 2010;26:1173-8.
29. Das CJ, Dinghra S, Gupta AK, Iyer VK, Agarwala S. Imaging of pediatric liver tumors with pathological correlation. Clin Radiol. 2009;64:1015-25.
30. Ortega J, Krailo MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Children Cancer Study Group. J Clin Oncol. 1991;9:2167-76.
31. von Schweinitz D, Hecker H, Schmidt-von-Arndt G, Harms D. Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer (Paed Oncol). 1997;74:593-9. (Pubitemid 28037500)
32. von Schweinitz D, Wischmeyer P, Leuschner I, et al. Clinicopathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer. 1994;30A:1052-8. (Pubitemid 24277824)
33. Iyer VK, Kapila K, Agarwala S, Verma K. Fine needle aspiration cytology of hepatoblastoma: recognition of subtypes on cytomorphology. Acta Cytol. 2005;49:355-64. (Pubitemid 41008825)
34. Clatworthy HW, Schiller M, Grosfeld JL. Primary liver tumors in infancy and childhood. 41 cases variously treated. Arch Surg. 1974;109:143-7.
35. McKinley GA, Pritchard J. A common language for childhood liver tumors. Pediatr Surg Int. 1992;7:325-6.
36. Czauderna P, Otte JB, Aronson DC, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era-recommendtions from the Childhood liver Tumor Strategy Group of the International Society of Pediatric Oncology (SIOPEL). Eur J Cancer. 2005;41:1031-6. (Pubitemid 40602855)
37. Evans AE, Land VJ, NewtonWA, et al. Combination chemotherapy (Vincristine, Adriamycin, cyclophosphamide and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer. 1982;50:821-6. (Pubitemid 12047109)
38. Douglass EC, Reynolds M, Finegold M, Cantor AB, Glicksman A. Cisplatin, vincristine and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1993;11:96-9. (Pubitemid 23059981)
39. Fuchs J, Rydzynski J, vonSchweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB94. Cancer. 2002;95:172-82. (Pubitemid 34743496)
40. Elias D, Cavalcanti A, Sabourin J-C, et al. Results of 16 curative hepatectomies with safety margin of less than 10 mm for colorectal metastases. J Surg Oncol. 1998;69:88-93. (Pubitemid 28515966)
41. Seo T, Ando H, Watnab Y, et al. Treatment of hepatoblastoma less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and Adriamycin. Surgery. 1998;123:407-14. (Pubitemid 28201221)
42. Dicken BJ, Bigam DL, Lees GM. Association between surgical margins and long-term outcome in advanced hepatoblastoma. J Pediatr Surg. 2004;39:721-5. (Pubitemid 38637922)
43. Pimpalwar AP, Sharif K, Ramani P, et al. Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J Pediatr Surg. 2002;37:240-5. (Pubitemid 34111545)
44. Nadalin S, Heuer M, Wallot M, et al. Paediatric acute liver failure and transplantation: the University of Essen experience. Transpl Int. 2007;20:519-27. (Pubitemid 46701079)
45. Rhee C, Narsinh K, Venick RS, et al. Predictors of clinical outcome in children undergoing orthotopic liver transplantation for acute and chronic liver disease. Liver Transpl. 2006;12:1347-56. (Pubitemid 44405124)
46. Mahadeb P, Gras J, Sokal E, et al. Liver transplantation in children with fulminant hepatic failure: the UCL experience. Pediatr Transplant. 2009;13:414-20.
47. Langevin AM, Pierro A, Liu P, et al. Adriamycin and cis-platinum administered by continuous infusion preoperatively in hepatoblastoma unresectable at presentation. Med Pediatr Oncol. 1990;18:181-4. (Pubitemid 20150569)
48. von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg. 2006;15:17-24. (Pubitemid 43177158)
49. Baertschinger RM, Hulya O, Rougemont A, et al. Cure of multifocal panhepatic hepatoblastoma: is liver transplantation always necessary. J Pediatr Surg. 2010;45:1030-6.
50. Tiao GM, Bobey N, Allen S, et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr. 2005;146:204-11. (Pubitemid 40202810)
51. Hemming AW, Reed AI, Langham Jr MR, et al. Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg. 2004;239:712-9.
52. Guerin F, Gauthier F, Martelli H, et al. Outcome of central hepatectomy for hepatoblastomas. J Pediatr Surg. 45:555-63.
53. Hemming AW, Reed AI, Langham MR, Fujita S, van derWerf WJ, Howard RJ. Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg. 2002;235:850-8. (Pubitemid 34547304)
54. Otte JB, de Ville de Goyet J, Reding R. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant. 2005;9:557-65. (Pubitemid 41413492)
55. Evans AE, Land VJ, Newton WA, Randolph JG, Sather HN, Tefft M. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer. 1982;50:821-6. (Pubitemid 12047109)
56. Douglass EC, Green AA, Wrenn E, Champion J, Shipp M, Pratt CB. Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol. 1985;13:187-90. (Pubitemid 15069801)
57. Quin JJ, Altman J, Robinson HT, Cooke RW, Hight DW, Foster JH. Adriamycin and Cisplatin for hepatoblastoma. Cancer. 1998;56:1926-9.
58. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000;18:2665-75. (Pubitemid 30463548)
59. Katzenstein HM, London WB, Douglass EC, et al. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. J Clin Oncol. 2002;20:3438-44.
60. Perilongo G, Maibach R, Shafford E, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med. 2009;361:1662-70.
61. Hishiki T, Matsunaga T, Sasaki F, et al. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int. 2011;27:1-8.
62. Häberle B, Bode U, von Schweinitz D. Differentiated treatment protocols for high-and standard-risk hepatoblastoma-an interim report of the German Liver Tumor Study HB99. Klin Padiatr. 2003;215:159-65. (Pubitemid 36718288)
63. Von Schweinitz D, Haberle B. German liver tumor study: HB 99. In: First International Symposium Childhood Hepatoblastoma. Poland: Gdansk; 2007.
64. Malogolowkin MH, Katzenstein HM, Krailo MD, et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol. 2006;24:2879-84. (Pubitemid 46630589)
65. Casanova M, Zsiros J, Brock P, et al. Metastatic hepatoblastoma-results of the Siopel 3 study from the International Childhood Liver Tumour Strategy Group-Siopel. 41st Annual Conference of the International Society of Paediatric Oncology,SIOP 2009. Pediatr Blood Cancer. 2009;53:744.
66. Sasaki F, Matsunaga T, Iwafuchi M, et al. Outcome of hepatoblastoma treatment with JPLT-1 protocol-1: a report from the Japanese study group for pediatric liver tumor. J Pediatr Surg. 2002;37:851-6. (Pubitemid 34575792)
67. Shukla PJ, Barreto SG, Qureshi SS, et al. Hepatoblastoma: a single institutional experience of 18 cases. Pediatr Surg Int. 2008;24:799-802.
68. Singh T, Satheesh CT, Appaji L, et al. Hepatoblastoma: experience from single center. Indian J Cancer. 2010;47:314-6.
69. Agarwala S, Bakshi S, Bajpai M, et al. Validation of PRETEXT staging system and risk categorization for prognostication and outcome in hepatoblastoma-Results from AIIMS-HB 94 trial. Pediatr Blood Cancer. 2007;49:401.
70. Hadley GP, Govender D, Landers G. Primary tumors of the liver in children: an African perspective. Pediatr Surg Int. 2004;20:314-8. (Pubitemid 38962891)
71. Czauderna P, MacKinley G, Perilongo G, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol. 2002;20:2798-804. (Pubitemid 34651508)
72. Pawlik TM, Scroggins CR, Thomas MB, Vauthey J-N. Advances in surgical management of liver malignancies. Cancer J. 2004;10:74-87. (Pubitemid 44403473)
73. Van Spronson FJ, Bijleveldem M, van Maldegem BT, Wijburg IA. Hepatocellular carcinoma in hereditary tyrosinemia type 1 despite 2 (-2 nitro 4-3 trifluoro-methyl-benzenyl) 1-3 cyclohexanedione therapy. J Pediatr Gastroenterol Nutr. 2005;40:90-3. (Pubitemid 40180065)
74. Bianchi L. Glycogen storage disease I and hepatocellular tumors. Eur J Pediatr. 1993;152:563-70.
75. Hadzic N, Quaglia A, Mieli-Vergani G. Hepatocellular carcinoma in a 12 y old child with PiZZ alpha-I-antitrypsin deficiency. Hepatology. 2006;43:514-21.
76. Halvorsen RAJ, Garrity S, Kun C, et al. Co-existing hepatocellular carcinoma in a patient with arteriohepatic dysplasia. Abdom Imaging.1995;20:191- 6.
77. Pennington DJ, Sivit CJ, Chandra RS. Hepatocellular carcinoma in a child with Niemann-Pick disease. Imaging findings Pediatr Radiol. 1996;26:220-1. (Pubitemid 26089404)
78. Zimmermann A. Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients. Med Pediatr Oncol. 2002;39:487-91.
79. Katzenstein HM, Krailo MD,MalogolowkinMH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003;97:2006-12. (Pubitemid 36397279)
80. nd ed, Springer:2008. pp. 227-60.
81. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup Study. J Clin Oncol. 2002;20:2789-97. (Pubitemid 34651507)
82. Mazzaferro V, Regalia E, Doci R, et al. Liver transplant for the treatment of hepatocellular carcinoma in patients with cirrhosis. N Eng J Med. 1996;334:696-9.
83. Chowdhary SK, Trehan A, Das A, et al. Undifferentiated embryonal sarcoma in children: beware of the solitary liver cyst. J Pediatr Surg. 2004;39:9-12.
84. Bisogno G, Pilz T, Perilongo G, et al. Undifferentiated sarcoma of the liver in childhood: a curable disease. Cancer. 2002;94:252-7. (Pubitemid 34049066)
85. Kim DY, Kim KH, Jung SE, Lee SC, Park KW, Kim WK. Undifferentiated (embryonal) sarcoma of the liver: combination treatment by surgery and chemotherapy. J Pediatr Surg. 2002;37:1419-23.
86. Baron PW, Majiessipour F, Bedros AA, et al. Undifferentiated embryonal sarcoma of theliver successfully treated with chemotherapy and liver resection. J Gastrointest Surg. 2007;11:73-5.
87. Awan S, Davenport M, Portmann B, Howard ER. Angiosarcoma of the liver in children. J Pediatr Surg. 1996;31:1729-32. (Pubitemid 26425577)
88. Nazir Z, Pervez S. Malignant vascular tumors of liver in neonates. J Pediatr Surg. 2006;41:e49-51. (Pubitemid 43067545)
89. Clairotte A, Ringenbach R, Laithier V, Aubert D, Kantelip B. Malignant rhabdoid tumor of the liver with spontaneous rupture: a case report. Ann Pathol. 2006;26:122-5. (Pubitemid 43952794)
90. Ravindra KV, Cullinane C, Lewis IJ, Squire BR, Stringer MD. Long-term survival after spontaneous ruptureof a malignant rhabdoid tumor of the liver. J Pediatr Surg. 2002;37:1488-90.